Les produits injectables et leur place dans le traitement de l'incontinence urinaire d'effort. [Bulking agents and their place in the treatment of urinary stress incontinence]

Details

Serval ID
serval:BIB_F93A03013DFE
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Les produits injectables et leur place dans le traitement de l'incontinence urinaire d'effort. [Bulking agents and their place in the treatment of urinary stress incontinence]
Journal
Gynakologisch-Geburtshilfliche Rundschau
Author(s)
Achtari  C., Meyer  S., De Grandi  P.
ISSN
1018-8843 (Print)
Publication state
Published
Issued date
2006
Volume
46
Number
1-2
Pages
39-44
Notes
English Abstract
Journal Article
Meta-Analysis
Abstract
Bulking agents are used in the treatment of urinary stress incontinence associated with intrinsic sphincter deficiency. Bovine collagen remains the gold standard despite problems such as allergic reaction and absorption of the injected material. Several new products are being evaluated or used clinically to try and overcome problems linked with bovine collagen. The aim of this paper is to review the bulking agents available and to put in prospect use of these products with the recent progress made in the treatment of urinary stress incontinence. The gold standard treatment for intrinsic sphincter deficiency is suburethral autologous or synthetic suburethral slings. Bulking agents are indicated for multi-operated patients with urinary stress incontinence and intrinsic sphincter deficiency. Bladder neck hypermobility is not a contraindication.
Keywords
*Biocompatible Materials Female Follow-Up Studies Humans Injections *Prostheses and Implants Recurrence Retreatment Urethra Urinary Incontinence, Stress/physiopathology/*therapy Urodynamics/physiology
Pubmed
Create date
25/01/2008 16:39
Last modification date
20/08/2019 17:25
Usage data